Читать книгу The Esophagus - Группа авторов - Страница 243

1 1 Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil 1991; 3:151–162.

2 2 Imam H, Shay S, Ali A, Baker M. Bolus transit patterns in healthy subjects: a study using simultaneous impedance monitoring, videoesophagram, and esophageal manometry. Am J Physiol Gastrointest Liver Physiol 2005; 288:G1000–1006.

3 3 Srinivasan R, Vela MF, Katz PO, et al. Esophageal function testing using multichannel intraluminal impedance. Am J Physiol Gastrointest Liver Physiol 2001; 280:G457–462.

4 4 Tutuian R, Vela MF, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol 2003; 37:206–215.

5 5 Tutuian R, Vela MF, Balaji N, et al. Esophageal function testing using combined multichannel intraluminal impedance and manometry. Multicenter study in healthy volunteers. Clin Gastroenterol Hepatol 2003; 1:174–182.

6 6 Tutuian R, Castell DO. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol 2004; 99:1011–1019.

7 7 Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995; 108:1897–1907.

8 8 Hirano I, Richter JE. American College of Gastroenterology guidelines: esophageal reflux testing. Am J Gastroenterol 2007; 102:668–685.

9 9 Vela M. Nonacid reflux: detection by multichannel intraluminal impedance and pH. Clinical significance and management. Am J Gastroenterol 2009; 104:277–280.

10 10 Vela MF, Camacho‐Lobato L, Srinivasan R, et al. Intraesophageal impedance and pH measurement of acid and nonacid reflux: effect of omeprazole. Gastroenterology 2001; 120:1599–1606.

11 11 Sifrim D, Holloway RH, Silny J, et al. Composition of the post‐prandial refluxate in patients with gastroesophageal reflux disease. Am J Gastroenterol 2001; 96:647–655.

12 12 Mainie I, Tutuian R, Shay S, et al. Acid and nonacid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance‐pH monitoring. Gut 2006; 55:1398–1402.

13 13 Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol 2007; 5:172–177.

14 14 Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in Symptomatic patients on PPI therapy. Am J Gastroenterol 2005; 100:283–289.

15 15 Stein HJ, Feussner H, Kauer W, et al. Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg 1994; 167:163–168.

16 16 Velasco N, Pope CE, Gannan RM, et al. Measurement of esophageal reflux by scintigraphy. Dig Dis Sci 1984, 29:977–982.

17 17 Iftikhar SY, Ledingham S, Evans DF, et al. Alkaline gastrooesophageal reflux: dual probe pH monitoring. Gut 1995; 37:465–470.

18 18 Vaezi MF, Richter JE. Importance of duodeno‐gastro‐esophageal reflux in the medical outpatient practice. Hepatogastroenterology 1999; 46:40–47.

19 19 Stein HJ, Kauer WKH, Feussner H, et al. Bile acids as components of the duodenogastric refluxate: detection, relationship to bilirubin, mechanism of injury, and clinical relevance. Hepatogastroenterology 1999; 46:66–73.

20 20 Girelli CM, Cuvello P, Limido E, et al. Duodenogastric reflux: an update. Am J Gastroenterol 1996; 91:648–653.

21 21 DeVault KR, Georgeson S, Castell DO. Salivary stimulation mimics esophageal exposure to refluxed duodenal contents. Am J Gastroenterol 1993; 88:1040–1043.

22 22 Smout AJPM. Ambulatory monitoring of esophageal pH and pressure. In: Castell DO, Richter JE, eds. The Esophagus, 3rd edn. Philadelphia: Lippincott Williams & Wilkins; 1999, pp. 119–133.

23 23 Agrawal A, Tutian R, Hila A, et al. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci 2005; 50:1916–1920.

24 24 Silny J, Knigge KP, Fass J, et al. Verification of the intraluminal multiple electrical impedance measurement for the recording of gastrointestinal motility. J Gastrointest Motil 1993; 5:107–122.

25 25 Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro‐oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, nonacid, and gas reflux. Gut 2004; 53:1024–1031.

26 26 Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Reproducibility of multichannel intraluminal electrical impedance monitoring of gastroesophageal reflux. Am J Gastroenterol 2005; 100:265–269.

27 27 Shay S, Tutuian R, Sifrim D, et al. Twenty‐four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004; 99:1037–1043.

28 28 Zerbib F, des Varannes SB, Roman S, et al. Normal values and day‐to‐day variability of 24‐h ambulatory oesophageal impedance‐pH monitoring in a Belgian‐French cohort of healthy subjects. Aliment Pharmacol Ther 2005; 22:1011–1021.

29 29 Pandolfino JE, Vela MF. Esophageal reflux monitoring. Gastrointest Endosc 2009; 69:917–930.

30 30 Roman S, Bruley des Varannes S, et al. Ambulatory 24‐h oesophageal impedance‐pH recordings: reliability of automatic analysis for gastro‐oesophageal reflux assessment. Neurogastroenterol Motil 2006; 18:978–986.

31 32 Jung KW, Jung HY, Romero Y, Katzka D, Murray JA. Impact of display alternatives in the determination of bolus handling: a study using high‐resolution manometry with impedance. Am J Gastroenterol. 2011; 106(10):1854–1857. doi:10.1038/ajg.2011.233.

32 33 Lin Z, Nicodème F, Lin CYY et al. Parameters for quantifying bolus retention with high‐resolution impedance manometry. Neurogastroenterol Motil 2014; 26:929–36.

33 34 Chen CL, Yi CH. Clinical correlates of dysphagia to oesophageal dysmotility: studies using combined manometry and impedance. Neurogastroenterol Motil 2008; 20:611–7.

34 35 Clayton SB, Rife C, Kalbfleisch JH et al. Viscous impedance is an important indicator of abnormal esophageal motility. Neurogastroenterol Motil 2013; 25:563.

35 36 Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: Studies using combined impedancemanometry. Clin Gastroenterol Hepatol 2004; 2:230–6.

36 37 Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 2015; 27(2):160–174. doi:10.1111/nmo.12477.

37 38 Tutuian R, Mainie I, Agrawal A, Gideon RM, Katz PO, Castell DO. Symptom and function heterogenicity among patients with distal esophageal spasm: studies using combined impedance‐manometry. Am J Gastroenterol. 2006; 101(3):464–469. doi:10.1111/j.1572‐0241.2006.00408.x.

38 39 Bredenoord AJ, Weusten BL, Sifrim D, et al. Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut 2004; 53:1561–5.

39 40 Karamanolis G, Triantafyllou K, Tsiamoulos Z et al. Effect of sleep on excessive belching: a 24‐hour impedance‐pH study. J Clin Gastroenterol 2010; 44:332–4.

40 41 Hemmink GJM, Cate TL, Bredenoord AJ et al. Speech therapy in patients with excessive supragastric belching–a pilot study. Neurogastroenterol Motil 2010; 22:24.

41 42 Katzka DA. Simple office‐based behavioral approach to patients with chronic belching. Dis Esophagus 2013; 26:570–3.

42 43 Tutuian R, Castell DO. Rumination documented by using combined multichannel intraluminal impedance and manometry. Clin Gastroenterol Hepatol 2004; 2:340–3.

43 44 Kessing BF, Govaert F, Masclee AA, et al. Impedance measurements and high‐resolution manometry help to better define rumination episodes. Scand J Gastroenterol 2011; 46:1310–5.

44 45 Tucker E, Knowles K, Wright J et al. Rumination variations: aetiology and classification of abnormal behavioural responses to digestive symptoms based on high‐resolution manometry studies. Aliment Pharmacol Therap 2013; 37:263–74.

45 46 Rommel N, Tack J, Arts J, et al. Rumination or belching‐regurgitation? Differential diagnosis using oesophageal impedance‐manometry. Neurogastroenterol Motil 2010; 22:104.

46 47 Halland M, Parthasarathy G, Bharucha AE, et al. Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action. Neurogastroenterol Motil 2016; 28:384–91.

47 48 Kessing BF, Bredenoord AJ, Smout AJJ. Objective manometric criteria for the rumination syndrome. Am J Gastroenterol 2014; 109:52–9.

48 49 Heard R, Castell J, Castell DO, Pohl D. Characterization of patients with low baseline impedance on multichannel intraluminal impedance‐pH reflux testing. J Clin Gastroenterol 2012; 46(7):e55–e57. doi:10.1097/MCG.0b013e318247c319.

49 50 Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110:1982–96.

50 51 Barlow WJ, Orlando RC. Th e pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005; 128:771–8.

51 52 Tobey NA, Argote CM, Vanegas XC, et al. Electrical parameters and ion species for active transport in human esophageal stratified squamous epithelium and Barrett's specialized columnar epithelium. Am J Physio Gastrointest Liver Physiol 2007; 293:70.

52 53 Orlando RC, Bryson JC, Powell DW. Mechanisms of H+ injury in rabbit esophageal epithelium. Am J Physiol 1984; 246:24.

53 54 Tobey NA, Carson JL, Alkiek RA, et al. Dilated intercellular spaces: a morpho‐logical feature of acid reflux–damaged human esophageal epithelium. Gastroenterology 1996; 111:1200–5.

54 55 Caviglia R, Ribolsi M, Gentile M, et al. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non‐erosive gastro‐oesophageal reflux disease. Aliment Pharmacol Therap 2007; 25:629–36.

55 56 Orlando LA, Orlando RC. Dilated intercellular spaces as a marker of GERD. Curr Gastroenterol Rep 2009; 11:190–4.

56 57 Kandulski A, Weigt J, Caro C, et al. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn. Clin Gastroenterol Hepatol 2015; 13:1075–81.

57 58 Kessing BF, Bredenoord AJ, Weijenborg PW, et al. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol 2011; 106:2093–7.

58 59 Martinucci I, de Bortoli N, Savarino E, et al. Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil 2014; 26:546–55.

59 60 de Bortoli N, Martinucci I, Savarino E, et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol 2015; 13:1082–8.

60 61 Waśko‐Czopnik D, Błoński W, Paradowski L. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus. Adv Med Sci 2007; 52:196–8.

61 62 Hemmink GJ, Alvarez Herrero L, Bogte A, et al. Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation. Eur J Gastroenterol Hepatol 2013; 25:1024–32.

62 63 Ravi K, Katzka DA. Esophageal impedance monitoring: clinical pearls and pitfalls. Am J Gastroenterol. 2016; 111(9):1245–1256. doi:10.1038/ajg.2016.256.

63 64 Fass R, Hell R, Sampliner RE, et al. Effect of ambulatory 24‐hour esophageal pH monitoring on reflux‐provoking activities. Dig Dis Sci 1999; 44(11):2263–2269. doi:10.1023/a:1026608804938.

64 65 Pandolfino JE, Schreiner MA, Lee TJ, Zhang Q, Boniquit C, Kahrilas PJ. Comparison of the Bravo wireless and Digitrapper catheter‐based pH monitoring systems for measuring esophageal acid exposure. Am J Gastroenterol 2005; 100(7):1466–1476. doi:10.1111/j.1572‐0241.2005.41719.x.

65 66 Patel DA, Higginbotham T, Slaughter JC, et al. Development and validation of a mucosal impedance contour analysis system to distinguish esophageal disorders. Gastroenterology 2019; 156(6):1617–1626.e1. doi:10.1053/j.gastro.2019.01.253.

66 67 Katzka DA, Tadi R, Smyrk TC, et al. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014; 12(11):1824–9.e1. doi:10.1016/j.cgh.2014.02.039.

67 68 Katzka DA, Ravi K, Geno DM, et al. Endoscopic mucosal impedance measurements correlate with eosinophilia and dilation of intercellular spaces in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2015; 13(7):1242–1248.e1. doi:10.1016/j.cgh.2014.12.032.

68 69 Lowry MA, Vaezi M, Correa H, Higginbotham T, Slaughter JC, Acra S. An innovative mucosal impedance device differentiates active eosinophilic esophagitis from inactive disease, NERD and controls. Gastrointestinal Endoscopy 2016 May 1; 83(5):AB166.

69 70 Yuksel ES, Higginbotham T, Slaughter JC, et al. Use of direct, endoscopic‐guided measurements of mucosal impedance in diagnosis of gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012; 10(10):1110–1116. doi:10.1016/j.cgh.2012.05.018.

70 71 Ates F, Yuksel ES, Higginbotham T, et al. Mucosal impedance discriminates GERD from non‐GERD conditions. Gastroenterology 2015; 148:334–43.

71 72 van Rhijn BD, Verheij J, van den Bergh Weerman MA, et al. Histological response to fluticasone propionate in patients with eosinophilic esophagitis is associated with improved functional esophageal mucosal integrity. Am J Gastroenterol 2015; 110:1289–97.

72 73 Katzka DA, Ravi K, Geno DM, et al. Endoscopic mucosal impedance measurements correlate with eosinophilia and dilation of intercellular spaces in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2015; 13:1242–12480.

73 74 Zheng E, Gideon RM, Sloan J, Katz PO. Esophagogastric junction outflow obstruction is often associated with coexistent abnormal esophageal body motility and abnormal bolus transit. Dis Esophagus. 2017; 30(10):1–4. doi:10.1093/dote/dox066.

74 75 Jain A, Baker JR, Rubenstein JH, Chen JW. Bolus clearance in esophagogastric junction outflow obstruction is associated with strength of peristalsis. Neurogastroenterol Motil. 2017; 29(9):10.1111/nmo.13093. doi:10.1111/nmo.13093.

75 76 Song BG, Min YW, Lee H, Min BH, Lee JH, Rhee PL, Kim JJ. Combined multichannel intraluminal impedance and high‐resolution manometry improves detection of clinically relevant esophagogastric junction outflow obstruction. J Neurogastroenterol Motil 2019; 25(1):75–81. https://doi.org/10.5056/jnm18148.

76 77 Beveridge C, Lynch K. Diagnosis and management of esophagogastric junction outflow obstruction. J. Gastroenterol Hepatol 2020; 16(3):131.